Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

by | May 2, 2025 | Clinical Trials | 0 comments

​ Conditions: Relapsing Remitting Multiple Sclerosis

Sponsors: Elpen Pharmaceutical Co. Inc.; AHEPA University Hospital

Not yet recruiting Conditions: Relapsing Remitting Multiple Sclerosis
Sponsors: Elpen Pharmaceutical Co. Inc.; AHEPA University Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *